See the DrugPatentWatch profile for Oxaprozin
Who manufactures oxaprozin API in Europe?
Oxaprozin (an oxicam NSAID) is produced as an active pharmaceutical ingredient (API) by API manufacturers and contract manufacturers, but the specific “Europe producer” depends on the legal entity, the market (EU vs. UK), and the specific grade/specification used.
To identify the right Europe producer, the most reliable route is to look up:
- The company listed in regulatory submissions for the oxaprozin products authorized in the EU (or the UK).
- The named API manufacturer(s) shown on product documentation (e.g., marketing-authorisation-related documents and product labels, when accessible).
How can I find the exact “API producer” for oxaprozin in Europe?
Because “API producer” can mean different things (original API maker vs. a contract API packager, and different suppliers per strength/manufacturer), you usually need to match your target product to its dossier/label information.
Search typically starts with:
- EU product authorization databases for the specific oxaprozin product name/MAH (marketing authorization holder).
- The API/manufacturer section in public pharmaceutical documentation associated with that product (where available).
- Supply-chain listings maintained by wholesalers or by regulatory affairs databases (often paid).
If you share the country (e.g., Germany/France/Netherlands) and the exact finished product you care about (brand or marketing authorisation holder), I can help narrow what to look for and how to trace the likely API manufacturer.
Is oxaprozin API produced by “API suppliers” or by the brand company?
For many small-molecule APIs like oxaprozin, production can be split across:
- An API manufacturer making oxaprozin API (often for multiple customers), and
- A finished-dose manufacturer/MAH sourcing the API from one of several qualified suppliers.
So the company you see associated with the finished product is often not the API producer.
Are there quality or regulatory details that matter for European oxaprozin API?
For oxaprozin API supply in the EU, buyers typically check:
- GMP compliance for the API manufacturing site (EU GMP expectations).
- CoA (certificate of analysis) and typical impurity/spec limits required by the finished-dose marketing authorization.
- Whether the supplier is qualified for the specific finished-dose specification.
Quick questions to pinpoint the “Europe producer”
1) Which oxaprozin product do you mean (brand name or marketing authorization holder)?
2) Which country market (EU country, or UK)?
3) Do you need the API manufacturer name, the site location, or both?
If you answer those, I can guide you to the most direct way to identify the specific Europe-based oxaprozin API producer that matches your target.